Blueridge Cancer Care

Salem, Virginia 24153

2 studies enrolling now · 6 studies all time

What they study most

Anal Squamous Cell Carcinoma, Cancer of the Prostate, Carcinoma, Non-Small-Cell Lung, Cervical Squamous Cell Carcinoma, Colorectal Cancer, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Hormone Sensitive Prostate Cancer, KRAS p.G12C Mutant Advanced Solid Tumors, Lung Squamous Cell Carcinoma, Metastatic Castration Sensitive Prostate Cancer (mCSPC), Penile Squamous Cell Carcinoma

Studies at this site

• This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve. — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer — Recruiting now
• A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions — Running, not enrolling
• A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100) — Completed
• Oral Rigosertib for Squamous Cell Carcinoma — Completed
• A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer — Completed